Septerna Inc Septerna Inc

Septerna Inc

SEPN

Rank in Stocks #5787
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops... Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves’ disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women’s health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Share Price
$42.60
Last synced: 2026-11-13
Market Cap
$2.00B
Change (1 day)
1.77%
Change (1 year)
79.22%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
Operating Margin for Septerna Inc (SEPN)
Operating Margin as of November 2026 TTM: -76.23%
According to Septerna Inc's latest financial reports, its current operating margin (TTM) is -76.23%. At the end of 2025 the company had an operating margin of -175.83%.
Operating Margin history for Septerna Inc from 2022 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -76.23% -56.65%
2025 -175.83% -97.66%
2024 -7,518.42% -647.12%
2023 1,374.17% 0.00%
2022 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -97.44%
US
33.87% -100.44%
US
-116.04% -98.48%
US
25.57% -100.34%
AU
31.23% -100.41%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Septerna Inc's operating margin

What is Septerna Inc's operating margin?

Septerna Inc's operating margin is -76.23%, as of Nov 2026.

What was Septerna Inc's operating margin in 2025?

In 2025, Septerna Inc's operating margin was -175.83%, compared with -7,518.42% in 2024.

How has Septerna Inc's operating margin changed since 2022?

From 2022 to 2025, Septerna Inc's operating margin was highest in 2023 (1,374.17%) and lowest in 2024 (-7,518.42%).

How does Septerna Inc's operating margin compare with similar companies?

Septerna Inc's operating margin (-76.23%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.